Skip to main content

Advertisement

Log in

miR-149 promotes human osteocarcinoma progression via targeting bone morphogenetic protein 9 (BMP9)

  • Original Research Paper
  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

Objectives

To investigate the roles of miR-149 in the progression of human osteosarcoma (OS).

Results

miR-149 level was upregulated in tissues from OS patients more than in normal subjects. Cell proliferation and apoptosis assays revealed that miR-149 increased cell proliferation and inhibited cell apoptosis in OS cell line (MG63). An increase of Bcl-2 gene expression and a decrease of cleaved-caspase-3, and cleaved-PARP expression were observed in MG63 cells with transfection of miR-149. Additionally, bone morphogenetic protein 9 (BMP9) was identified as a target of miR-149 in MG63 cells, and BMP9 expression was negatively correlated with miR149 level in OS clinical samples. Co-overexpression of BMP9 with miR-149 in MG63 cells prohibited miR-149-mediated promotive effects on OS progression. Importantly, overexpression of miR-149 conferred chemoresistance in MG63 cells.

Conclusions

miR-149 promotes OS progression via targeting BMP9.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Cimpeanu RA, Popescu DM, Burada F, Cucu MG, Gheonea DI, Ioana M, Rogoveanu I (2017) miR-149 rs2292832 C > T polymorphism and risk of gastric cancer. Rom J Morphol Embryol 58:125–129

    PubMed  Google Scholar 

  • Durfee RA, Mohammed M, Luu HH (2016) Review of osteosarcoma and current management. Rheumatol Ther 3:221–243

    Article  PubMed  PubMed Central  Google Scholar 

  • Ghasemi A, Fallah S, Ansari M (2016) MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin D1 in human glioblastoma multiforme. Biochem Cell Biol 94:569–576

    Article  CAS  PubMed  Google Scholar 

  • Li X, Zheng L, Zhang F, Hu J, Chou J, Liu Y, Xing Y, Xi T (2016) STARD13-correlated ceRNA network inhibits EMT and metastasis of breast cancer. Oncotarget 7:23197–23211

    PubMed  PubMed Central  Google Scholar 

  • Tian P, Yan L (2016) Inhibition of microRNA-149-5p induces apoptosis of acute myeloid leukemia cell line THP-1 by targeting Fas ligand (FASLG). Med Sci Monit 22:5116–5123

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang Y, Lin G (2016) TP53INP1 3′-UTR functions as a ceRNA in repressing the metastasis of glioma cells by regulating miRNA activity. Biotechnol Lett 38:1699–1707

    Article  CAS  PubMed  Google Scholar 

  • Wang F, Jiang Y, Huang X, Liu Q, Zhang Y, Luo W, Zhang F, Zhou P, Lin J, Zhang H (2017a) Pro-inflammatory cytokine TNF-alpha attenuates BMP9-induced osteo/odontoblastic differentiation of the stem cells of dental apical papilla (SCAPs). Cell Physiol Biochem 41:1725–1735

    Article  CAS  PubMed  Google Scholar 

  • Wang J, Liao J, Zhang F, Song D, Lu M, Liu J, Wei Q, Tang S, Liu H, Fan J et al (2017b) NEL-like molecule-1 (Nell1) is regulated by bone morphogenetic protein 9 (BMP9) and potentiates BMP9-induced osteogenic differentiation at the expense of adipogenesis in mesenchymal stem cells. Cell Physiol Biochem 41:484–500

    Article  CAS  PubMed  Google Scholar 

  • Xu Y, Chen X, Lin L, Chen H, Yu S, Li D (2017) MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification. Biochimie 139:1–8

    Article  CAS  PubMed  Google Scholar 

  • Yan P, Xia M, Gao F, Tang G, Zeng H, Yang S, Zhou H, Ding D, Gong L (2015) Predictive role of miR-146a rs2910164 (C > G), miR-149 rs2292832 (T > C), miR-196a2 rs11614913 (T > C) and miR-499 rs3746444 (T > C) in the development of hepatocellular carcinoma. Int J Clin Exp Pathol 8:15177–15183

    PubMed  PubMed Central  Google Scholar 

  • Yuan G, Zhao Y, Wu D, Gao C (2017a) Mir-150 up-regulates Glut1 and increases glycolysis in osteosarcoma cells. Asian Pac J Cancer Prev 18:1127–1131

    PubMed  PubMed Central  Google Scholar 

  • Yuan Z, Mo H, Mo L, He J, Wu Z, Lin X (2017b) Suppressive effect of microRNA-138 on the proliferation and invasion of osteosarcoma cells via targeting SIRT1. Exp Ther Med 13:3417–3423

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhang J, Liang JH, Huang JG (2016) Bone morphogenetic protein 9 facilitates osteocarcinoma cell apoptosis and inhibits in vivo tumor growth. Genet Mol Res. doi:10.4238/gmr.15038036

    Google Scholar 

  • Zhang G, Liu X, Li Y, Wang Y, Liang H, Li K, Li L, Chen C, Sun W, Ren S et al (2017) EphB3-targeted regulation of miR-149 in the migration and invasion of human colonic carcinoma HCT116 and SW620 cells. Cancer Sci 108:408–418

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhao J, Cheng L (2017) Long non-coding RNA CCAT1/miR-148a axis promotes osteosarcoma proliferation and migration through regulating PIK3IP1. Acta Biochim Biophys Sin (Shanghai) 49:503–512

    Article  Google Scholar 

Download references

Supporting information

Supplementary Table 1—shRNA for BMP9 and PCR Primer sequences.

Supplementary Figure 1—The pictures of Amplification Plot and Melt Curve of BMP9, GAPDH and miR-149.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuxing Qu.

Ethics declarations

Conflicts of interest

The authors declare no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 519 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xie, Z., Xu, J., Peng, L. et al. miR-149 promotes human osteocarcinoma progression via targeting bone morphogenetic protein 9 (BMP9). Biotechnol Lett 40, 47–55 (2018). https://doi.org/10.1007/s10529-017-2445-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10529-017-2445-8

Keywords

Navigation